A fast and reliable method for monitoring genomic instability in the model organism Caenorhabditis elegans

被引:0
|
作者
Merle Marie Nicolai
Barbara Witt
Andrea Hartwig
Tanja Schwerdtle
Julia Bornhorst
机构
[1] University of Wuppertal,Food Chemistry, Faculty of Mathematics and Natural Sciences
[2] University of Potsdam,Department of Food Chemistry, Institute of Nutritional Science
[3] Karlsruhe Institute of Technology (KIT),Department of Food Chemistry and Toxicology, Institute of Applied Biosciences
[4] TraceAge-DFG Research Unit on Interactions of Essential Trace Elements in Healthy and Diseased Elderly (FOR 2558),undefined
来源
Archives of Toxicology | 2021年 / 95卷
关键词
Alkaline unwinding; Genomic instability;
D O I
暂无
中图分类号
学科分类号
摘要
The identification of genotoxic agents and their potential for genotoxic alterations in an organism is crucial for risk assessment and approval procedures of the chemical and pharmaceutical industry. Classically, testing strategies for DNA or chromosomal damage focus on in vitro and in vivo (mainly rodent) investigations. In cell culture systems, the alkaline unwinding (AU) assay is one of the well-established methods for detecting the percentage of double-stranded DNA (dsDNA). By establishing a reliable lysis protocol, and further optimization of the AU assay for the model organism Caenorhabditis elegans (C. elegans), we provided a new tool for genotoxicity testing in the niche between in vitro and rodent experiments. The method is intended to complement existing testing strategies by a multicellular organism, which allows higher predictability of genotoxic potential compared to in vitro cell line or bacterial investigations, before utilizing in vivo (rodent) investigations. This also allows working within the 3R concept (reduction, refinement, and replacement of animal experiments), by reducing and possibly replacing animal testing. Validation with known genotoxic agents (bleomycin (BLM) and tert-butyl hydroperoxide (tBOOH)) proved the method to be meaningful, reproducible, and feasible for high-throughput genotoxicity testing, and especially preliminary screening.
引用
收藏
页码:3417 / 3424
页数:7
相关论文
共 50 条
  • [31] Research Advances on the Adverse Effects of Nanomaterials in a Model Organism, Caenorhabditis elegans
    Li, Yimeng
    Zhong, Lishi
    Zhang, Lili
    Shen, Xiaobing
    Kong, Lu
    Wu, Tianshu
    ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2021, 40 (09) : 2406 - 2424
  • [32] Ellsworth C. Dougherty: A Pioneer in the Selection of Caenorhabditis elegans as a Model Organism
    Ferris, Howard
    Hieb, W. F.
    GENETICS, 2015, 200 (04) : 991 - 1002
  • [33] Emergence of Caenorhabditis elegans as a Model Organism for Dissecting the Gut-Brain Axis
    de Ora, Lizett Ortiz
    Bess, Elizabeth N.
    MSYSTEMS, 2021, 6 (04)
  • [34] Genetic variation in neurodegenerative diseases and its accessibility in the model organism Caenorhabditis elegans
    Wang, Yiru Anning
    Kammenga, Jan Edward
    Harvey, Simon Crawford
    HUMAN GENOMICS, 2017, 11
  • [35] The use of the model organism Caenorhabditis elegans in the investigation of the adverse effects of electronic cigarettes
    Melnikov, Kamila
    Kaiglova, Alzbeta
    Kucharikova, Sona
    ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2025, 291
  • [36] Caenorhabditis elegans as a model organism for RYR1 variants and muscle ageing
    Kathie Nicoll Baines
    Marie-Anne Shaw
    Ian A Hope
    BMC Anesthesiology, 14 (Suppl 1)
  • [37] Caenorhabditis elegans, a model organism for kidney research: from cilia to mechanosensation and longevity
    Mueller, Roman-Ulrich
    Zank, Sibylle
    Fabretti, Francesca
    Benzing, Thomas
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2011, 20 (04): : 400 - 408
  • [38] Using Caenorhabditis elegans as a Model System to Study Protein Homeostasis in a Multicellular Organism
    Karady, Ido
    Frumkin, Anna
    Dror, Shiran
    Shemesh, Netta
    Shai, Nadav
    Ben-Zvi, Anat
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2013, (82):
  • [39] Impact of a Complex Food Microbiota on Energy Metabolism in the Model Organism Caenorhabditis elegans
    Zanni, Elena
    Laudenzi, Chiara
    Schifano, Emily
    Palleschi, Claudio
    Perozzi, Giuditta
    Uccelletti, Daniela
    Devirgiliis, Chiara
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [40] Caenorhabditis elegans Show Preference for Stimulants and Potential as a Model Organism for Medications Screening
    Engleman, Eric A.
    Steagall, Kevin B., II
    Bredhold, Kristin E.
    Breach, Michaela
    Kline, Hannah L.
    Bell, Richard L.
    Katner, Simon N.
    Neal-Beliveau, Bethany S.
    FRONTIERS IN PHYSIOLOGY, 2018, 9